Pathologic response to neoadjuvant therapy of high risk prostate cancer

Background. The role of pathological response, which develops as a result of systemic therapy for localized and locally advanced high risk prostate cancer, is not still fully understood. There are no clear indications for neoadjuvant therapy and no data on the relationship between neoadjuvant therap...

Full description

Bibliographic Details
Main Authors: M. V. Berkut, A. S. Artemjeva, S. S. Tolmachev, S. A. Reva, S. V. Petrov, A. K. Nosov
Format: Article
Language:Russian
Published: ABV-press 2020-11-01
Series:Onkourologiâ
Subjects:
Online Access:https://oncourology.abvpress.ru/oncur/article/view/1011